Hereditary angioedema treatment options: the availability of new therapies.
about
Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiencyHereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.Perioperative management for patients with hereditary angioedemaExpert perspectives on hereditary angioedema: Key areas for advancements in care across the patient journeyC1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.
P2860
Hereditary angioedema treatment options: the availability of new therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hereditary angioedema treatment options: the availability of new therapies.
@en
type
label
Hereditary angioedema treatment options: the availability of new therapies.
@en
prefLabel
Hereditary angioedema treatment options: the availability of new therapies.
@en
P2860
P1433
P1476
Hereditary angioedema treatment options: the availability of new therapies.
@en
P2093
Werner Aberer
P2860
P304
P356
10.3109/07853890.2012.687833
P407
P577
2012-07-11T00:00:00Z